1. Generic substitution in the treatment of epilepsy: Case evidence of breakthrough seizures;Berg;Neurology,2008
2. Clinical equivalence of generic and branded drugs used in cardiovascular disease: a systematic review and meta-analysis;Kesselheim;JAMA,2008
3. WHO/DMP/RGS. Marketing authorization of pharmaceutical products with spécial reference to multisource (generic) products: a manual for a drug regulatory authority. 1998.
4. European Medicals Agency. Guideline on the investigation of bioequivalence. www.ema.europa.eu/pdfs/human/qwp/140198enrev1fin.pdf
5. A survey of the quality of generic clarythromycin products from 18 countries;Nightingale;Clin Drug Invest,2005